{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:25:32Z","timestamp":1774427132694,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Estonian Research Council","award":["IUT 2\u20138"],"award-info":[{"award-number":["IUT 2\u20138"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The role of adipokines in the development of atherosclerosis in type 2 diabetes (T2DM) has not yet been fully elucidated. The effects of drugs on adipokine concentrations have only been evaluated in very few studies, although they may be of clinical importance. This study aimed to assess whether the concentrations of circulating adipokines could predict subclinical atherosclerosis in patients with T2DM, as well as their interactions with commonly used cardiovascular drugs. Materials and Methods: Our population-based cross-sectional multicentric study included 216 participants with T2DM but without previously diagnosed atherosclerosis. The carotid artery intima\u2013media thickness (IMT), plaque and ankle\u2013brachial index (ABI) metrics were measured. Resistin, visfatin, retinol-binding protein 4, high molecular weight adiponectin and leptin levels were evaluated using Luminex\u2019s xMAP technology. Results: Visfatin and resistin concentrations correlated positively with IMT (p = 0.002 and p = 0.009, respectively). The correlation of visfatin to IMT \u2265 1.0 mm was significant in males (p &lt; 0.001). Visfatin had a positive correlation with IMT \u2265 1.0 mm or plaque (p = 0.008) but resistin only correlated with plaque (p = 0.049). Visfatin predicted IMT \u2265 1.0 mm or plaque in patients on \u03b2-blocker monotherapy (p = 0.031). Visfatin lost its ability to predict subclinical atherosclerosis in patients taking angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers or statins. After adjustments for risk factors for atherosclerosis and cardiovascular drugs, visfatin maintained an independent association with mean IMT (p = 0.003), IMT \u2265 1.0 mm or plaque (p = 0.005) and ABI \u2264 0.9 (p = 0.029). Conclusions: Visfatin could be used as a marker of subclinical atherosclerosis in patients with T2DM, especially in males. The assessment of visfatin concentration could aid in identifying individuals who could benefit from implementing preventive measures against atherosclerosis.<\/jats:p>","DOI":"10.3390\/medicina59071324","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:47:38Z","timestamp":1689727658000},"page":"1324","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs"],"prefix":"10.3390","volume":"59","author":[{"given":"Kati","family":"K\u00e4rberg","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, University of Tartu, L. Puusepa 8, 50406 Tartu, Estonia"},{"name":"Internal Medicine Clinic, Tartu University Hospital, L. Puusepa 8, 50406 Tartu, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7416-9843","authenticated-orcid":false,"given":"Alastair","family":"Forbes","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Tartu, L. Puusepa 8, 50406 Tartu, Estonia"},{"name":"Internal Medicine Clinic, Tartu University Hospital, L. Puusepa 8, 50406 Tartu, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margus","family":"Lember","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Tartu, L. Puusepa 8, 50406 Tartu, Estonia"},{"name":"Internal Medicine Clinic, Tartu University Hospital, L. Puusepa 8, 50406 Tartu, Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"ref_1","unstructured":"International Diabetes Federation (2021). IDF Diabetes Atlas, International Diabetes Federation. [10th ed.]. Available online: https:\/\/www.diabetesatlas.org."},{"key":"ref_2","unstructured":"Lobstein, T., Brinsden, H., Neveux, M., Barata Cavalcanti, O., Barquera, S., Baur, L., Busch, V., Buse, K., Dietz, B., and French, A. (2023, January 29). World Obesity Atlas 2022. Available online: https:\/\/www.worldobesity.org#worldobesityatlas."},{"key":"ref_3","unstructured":"(2023, January 29). ICD-11 for Mortality and Morbidity Statistics. Available online: https:\/\/icd.who.int\/browse11\/l-m\/en#\/http:\/\/id.who.int\/icd\/entity\/149403041."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","article-title":"Adipokines, adiposity, and atherosclerosis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/01.STR.0000190834.00284.fd","article-title":"Plasma Adiponectin Levels and Sonographic Phenotypes of Subclinical Carotid Artery Atherosclerosis Data from the SAPHIR Study","volume":"36","author":"Iglseder","year":"2005","journal-title":"Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1210\/jc.2003-031676","article-title":"Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes","volume":"89","author":"Reilly","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12933-018-0723-y","article-title":"Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: A retrospective study","volume":"17","author":"Yang","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2008.08.012","article-title":"Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus","volume":"204","author":"Park","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis Possible Role in Inflammation and Plaque Destabilization","volume":"115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1365-2362.2012.02728.x","article-title":"Adipokines: A novel link between adiposity and carotid plaque vulnerability","volume":"42","author":"Kadoglou","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2010.09.012","article-title":"Serum levels of vaspin and visfatin in patients with coronary artery disease\u2014Kozani study","volume":"412","author":"Kadoglou","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"469852","DOI":"10.1155\/2012\/469852","article-title":"Increased expression of visfatin in monocytes and macrophages in male acute myocardial infarction patients","volume":"2012","author":"Chiu","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0029-1243638","article-title":"Visfatin\/PBEF\/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans","volume":"42","author":"Laudes","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.11622\/smedj.2014091","article-title":"Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular disease","volume":"55","author":"Kong","year":"2014","journal-title":"Singap. Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/157016110790226679","article-title":"Visfatin\/PBEF and atherosclerosis-related diseases","volume":"8","author":"Filippatos","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2265.2008.03248.x","article-title":"Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis","volume":"69","author":"Zhong","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00592-011-0310-0","article-title":"Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes","volume":"49","author":"Kadoglou","year":"2011","journal-title":"Acta Diabetol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.20452\/pamw.3390","article-title":"Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations","volume":"126","author":"Skoczylas","year":"2016","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/hr.2010.205","article-title":"Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients","volume":"34","author":"Derosa","year":"2011","journal-title":"Hypertens. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1365-2362.2008.02025.x","article-title":"Angiotensin inhibition stimulates PPAR\u03b3 and the release of visfatin","volume":"38","author":"Storka","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/hr.2010.85","article-title":"Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients","volume":"33","author":"Derosa","year":"2010","journal-title":"Hypertens. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_24","unstructured":"(2023, July 14). IPAQ Research Committee, Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ)\u2013Short Form. Version 2.0. April 2004. Available online: https:\/\/www.physio-pedia.com\/images\/c\/c7\/Quidelines_for_interpreting_the_IPAQ.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"147","author":"Altman","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/00365513.2021.1904279","article-title":"Subclinical atherosclerosis in the carotid artery: Can the ankle-brachial index predict it in type 2 diabetes patients?","volume":"81","author":"Lember","year":"2021","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular","volume":"21","author":"Stein","year":"2008","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000081812","article-title":"Mannheim intima-media thickness consensus","volume":"18","author":"Touboul","year":"2004","journal-title":"Cerebrovasc. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the Ankle-Brachial Index: A scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1747-4949.2006.00068.x","article-title":"Measurement of intima-media thickness vs. carotid plaque: Uses in patient care, genetic research and evaluation of new therapies","volume":"1","author":"Spence","year":"2006","journal-title":"Int. J. Stroke"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diabres.2011.05.039","article-title":"The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance","volume":"94","author":"Lan","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MBP.0000000000000245","article-title":"Visfatin levels are increased in patients with resistant hypertension and are correlated with left ventricular hypertrophy","volume":"22","author":"Ozal","year":"2017","journal-title":"Blood Press. Monit."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12012-021-09704-8","article-title":"Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1\/p53\/p21 Axis","volume":"22","author":"Li","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2007.09.019","article-title":"Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia","volume":"578","author":"Kostapanos","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/09513590.2014.911273","article-title":"Effect of simvastatin treatment on plasma visfatin levels in obese women","volume":"30","author":"Petreanu","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.metabol.2006.12.005","article-title":"Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians","volume":"56","author":"Sandeep","year":"2007","journal-title":"Metabolism"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/eci.12106","article-title":"Adiponectin, visfatin and regional fat depots in normal weight obese premenopausal women","volume":"43","author":"Miazgowski","year":"2013","journal-title":"Eur. J. Clin. Investig."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1324\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:14:00Z","timestamp":1760127240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/7\/1324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["medicina59071324"],"URL":"https:\/\/doi.org\/10.3390\/medicina59071324","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]}}}